DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Benzinga's Top #PreMarket Losers

Neurocrine Biosciences Inc. Nearly Doubles (but Not Really)

Neurocrine Biosciences isn't up nearly as much as it appears.

Neurocrine Biosciences' CEO Hosts Announcement of Positive Results of VMAT2 Inhibitor NBI-98854 in K

Neurocrine Biosciences' CEO Hosts Announcement of Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study Conference (Transcript)

Neurocrine Biosciences' CEO Presents at Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 St

Neurocrine Biosciences' CEO Presents at Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study Conference (Transcript)

Why Neurocrine Biosciences, Epizyme, and Plug Power Are Today's 3 Best Stocks

The S&P 500 delivers its first gain of the year while Neurocrine Biosciences, Epizyme, and Plug Power all rocket higher by at least 39%!

Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls on Citron Report

Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls on Citron Report

Why Epizyme, Neurocrine Biosciences, and Peregrine Soared

These 3 biotechs could beat the broader market this year.

Why Neurocrine Biosciences (NBIX) Is Spiking Today

Why Neurocrine Biosciences Inc. Shares Skyrocketed

Neurocrine shows short-minded investors why bailing during dose-escalation studies wasn't the smartest idea.
See More Articles...